iShares Russell 2000 Growth ETF (IWO)

231.04
Delayed Data
As of Dec 02
 +1.58 / +0.69%
Today’s Change
192.88
Today|||52-Week Range
301.64
-21.16%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the Russell 2000 Growth Index, which measures the performance of the small-capitalization growth sector of the U.S. equity market. The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index (i.e., depositary receipts representing securities of the underlying index) and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.

No recent news for iShares Russell 2000 Growth ETF.

Performance

1 month+5.86% 3 years+4.25%
3 months+4.09% 5 years+5.12%
1 year-20.21% Since inception+5.45%
Data through 12/03/2022

Quote Details

Previous close$229.46
Open day’s range226.97 – 232.13
Net asset value (NAV)231.08 (12/02/2022)
Daily volume332,327
Average volume (3 months)582,913
Data as of 3:59pm ET, 12/02/2022

Peer Comparisonvs. Small growth ETFs

 IWOCategory
Performance 5-yr return+5.12%+6.34%
Expense Gross exp ratio0.23%1.20%
Risk 5 year sharpe ratio0.280.38
Net assets$9.7B$961.1M
Average market cap$2.6B$4.5B
Average P/E15.222.7
Dividend / Share--0.11%

Competitors

VIOG Vanguard S&P Small-Cap 600 Growth Index ...
IJT iShares S&P Small-Cap 600 Growth ETF
SLYG SPDR® S&P 600 Small Cap Growth ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 16.90%
Industrial materials 12.87%
Hardware 11.74%
Consumer goods 11.16%
Consumer service 9.60%
Top 10 Holdings
Portfolio weighting
SWAV Shockwave Medical Inc0.86%
GTLS Chart Industries Inc0.68%
MTDR Matador Resources Co0.62%
EME EMCOR Group Inc0.57%
KNSL Kinsale Capital Group Inc0.57%
MUSA Murphy Usa Inc0.56%
TXRH Texas Roadhouse Inc0.55%
IRDM Iridium Communications Inc0.54%
KRTX Karuna Therapeutics Inc0.54%
HALO Halozyme Therapeutics Inc0.54%